A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 247.74
GOOG 1.110.71
MSFT 149.70
FB 156.79
BAC 21.60

Recently Added

SEDG 82.37
CLOU 14.69
CLVS 7.13
CODX 9.15
RLLCF 0.00

Gaining Speed

SEDG 82.37
CLVS 7.13
CODX 9.15
CLOU 14.69
ADXS 0.56

Advaxis Announces Updated Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC at I/O 360┬░ Conference

First two patients treated in the combination arm who previously progressed on KEYTRUDA® showed substantial tumor shrinkage with ADXS-503 treatment in combination with KEYTRUDA® Partial response observed in one patient and the other patient achieved stable disease with a 25% reduction in a target lesion PRINCETON, N.J., Feb. 27, 2020 ...

Read More




Get Alerted When News Hits On This Stock - FREE!